Rubric Capital Management LP - 31 Dec 2024 SCHEDULE 13G/A Report for Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share ("Common Stock") (TRVI)

Filing Manager: Rubric Capital Management LP
Reporting Manager: Rubric Capital Management LP
Security: Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share ("Common Stock")
Symbol: TRVI
Shares outstanding: 89,280,870 shares
Disclosed Ownership: 4,205,129 shares
Ownership: 4.71%
Form type: SCHEDULE 13G/A
Filing time: 13 Feb 2025, 16:01:36 UTC
Date of event: 31 Dec 2024
Next filing: 09 Jul 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Rubric Capital Management LP	4.71%	4,205,129	0	4,205,129	/s/ Michael Nachmani	Michael Nachmani / Chief Operating Officer
David Rosen	4.71%	4,205,129	0	4,205,129	/s/ David Rosen	David Rosen / individually